Federal agencyVerified2026-11-10
National Institutes of Health
- Opportunities linked
- 749
- Recorded awards (total)
- $343,986,917,930
- Median recorded award
- $1,389,099
Records in this library attributed to this funder.
Sum of the awards we hold for this funder. A floor on its giving, not a filing total.
The midpoint of the awards we hold, not a cap and not a filing median.
- Data year
- Not stated
The most recent fiscal year among the awards we hold, as the source wrote it.
Why there is no giving history here
Award listings from USASpending are not connected yet. What is missing here is a feed on our side, not a document this funder has failed to publish - the listings are public and we have not connected them.
Derived from awards
Computed from the 6185 recipients we hold an award to. This is where money we can see went, which is not the same as a statement of what this funder sets out to fund — and the gap between the two is widest where our coverage is thinnest.
Programmes, by money awarded
- 93.855$37,603,430,32515561 awards
- 93.866$29,021,542,69811627 awards
- 93.859$28,312,929,31613277 awards
- 93.310$22,220,294,2993736 awards
- 93.837$21,711,813,29711017 awards
- 93.847$20,477,692,9339106 awards
- 93.242$20,308,340,5918291 awards
- 93.853$18,160,521,43610218 awards
- 93.279$16,759,788,4556161 awards
- 93.865$10,420,201,8106701 awards
- 93.395$10,398,605,5384036 awards
- 93.393$8,078,626,7303174 awards
- 93.396$7,178,467,1553332 awards
- 93.867$7,162,557,7473728 awards
- 93.353$6,665,199,287368 awards
Where the recipients are
The recipient's own location, not where the work happens. A national body headquartered in Washington spends money everywhere.
- CA $50,938,613,617
- NY $32,730,825,586
- MA $32,454,347,850
- PA $21,607,377,645
- TX $17,326,857,077
- NC $16,128,234,289
- MD $13,827,501,501
- WA $13,333,544,408
- IL $11,586,075,768
- MI $9,623,652,266
- OH $9,479,655,836
- FL $8,296,714,094
- GA $7,815,511,712
- CT $7,707,871,399
- MO $7,634,736,082
- MN $7,038,906,424
- TN $6,990,621,609
- WI $5,987,857,328
- CO $5,099,432,348
- VA $4,522,276,190
Award sizes
Fixed bands rather than this funder's own quantiles, so two funders can be compared. A per-funder split would make every distribution look the same shape.
- 100k-500k 37850
- 25k-100k 7862
- 500k-2m 44760
- over-2m 52424
- under-25k 1730
By fiscal year
A trend across the years we import, which is a bounded window. A year with no bar is a year outside it, not a year with no funding.
- FY1972 $7,781,340 (1)
- FY1974 $17,410,828 (2)
- FY1975 $885,835,634 (85)
- FY1976 $365,364,825 (41)
- FY1977 $779,079,794 (70)
- FY1978 $856,246,890 (57)
- FY1979 $418,420,741 (52)
- FY1980 $279,044,614 (49)
- FY1981 $264,333,498 (35)
- FY1982 $301,003,827 (36)
- FY1983 $361,705,895 (49)
- FY1984 $362,336,430 (50)
- FY1985 $453,495,098 (70)
- FY1986 $291,563,314 (41)
- FY1987 $439,849,674 (56)
- FY1988 $449,613,873 (57)
- FY1989 $575,645,073 (79)
- FY1990 $504,466,405 (86)
- FY1991 $609,729,356 (105)
- FY1992 $1,258,274,572 (136)
- FY1993 $718,076,924 (101)
- FY1994 $1,147,789,348 (152)
- FY1995 $835,311,432 (130)
- FY1996 $949,862,020 (142)
- FY1997 $8,810,015,943 (338)
- FY1998 $2,627,436,906 (204)
- FY1999 $2,377,014,146 (259)
- FY2000 $2,668,676,999 (285)
- FY2001 $3,806,697,730 (337)
- FY2002 $2,392,113,600 (298)
- FY2003 $2,645,675,002 (307)
- FY2004 $2,535,014,039 (316)
- FY2005 $2,931,504,280 (376)
- FY2006 $7,529,332,889 (325)
- FY2007 $4,541,066,128 (431)
- FY2008 $2,855,953,166 (406)
- FY2009 $3,662,388,585 (531)
- FY2010 $4,284,896,872 (712)
- FY2011 $5,247,655,983 (828)
- FY2012 $5,693,007,232 (949)
- FY2013 $6,281,286,552 (1131)
- FY2014 $11,889,737,864 (1893)
- FY2015 $13,025,486,325 (3444)
- FY2016 $22,161,451,253 (6409)
- FY2017 $23,248,183,644 (8586)
- FY2018 $24,605,628,493 (11550)
- FY2019 $31,559,649,125 (13799)
- FY2020 $27,995,053,960 (15559)
- FY2021 $26,976,424,267 (15913)
- FY2022 $27,139,357,213 (16091)
- FY2023 $23,074,363,717 (15515)
- FY2024 $16,767,266,938 (14143)
- FY2025 $11,220,426,635 (11656)
- FY2026 $20,004,931 (224)
- FY2030 $54,659 (1)
Giving history, from the awards we hold
No dated awards on file for this funder
This table takes one row per fiscal year, built from the awards we hold. We have connected none for this funder that state a year, so there is nothing to group. That is a gap in our coverage, not a finding that the funder gave nothing.
Who has received money from this funder
144626 awards on file, largest first, ranging $-3,000,000 to $1,073,967,938.
| Recipient | State | Amount | Fiscal year |
|---|---|---|---|
| GIGAMUNE, INC. | Not stated | $400,000 | 2021 |
| GIGAMUNE, INC. | Not stated | $400,000 | 2021 |
| GIGAMUNE, INC. | Not stated | $400,000 | 2025 |
| HUMAN CELL CO | Not stated | $400,000 | 2023 |
| INTEGRATED MEDICAL SENSORS INC | Not stated | $400,000 | 2023 |
| IONTX INC. | Not stated | $400,000 | 2025 |
| IOWA STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY | Not stated | $400,000 | 2025 |
| KIBIO INC | Not stated | $400,000 | 2022 |
| KURE CELLS INC | Not stated | $400,000 | 2024 |
| LIFENGINE ANIMAL HEALTH LABORATORIES INCORPORATED | Not stated | $400,000 | 2025 |
| LIPO-IMMUNO TECH LLC | Not stated | $400,000 | 2022 |
| MEDIA REZ LLC | Not stated | $400,000 | 2020 |
| MICRO-LEADS INC | Not stated | $400,000 | 2023 |
| MOUNTAINPASS TECHNOLOGY LLC | Not stated | $400,000 | 2025 |
| MTI BIOTECH, INCORPORATED | Not stated | $400,000 | 2021 |
| NANOCAN THERAPEUTICS CORPORATION | Not stated | $400,000 | 2022 |
| NAVEGA THERAPEUTICS, INC. | Not stated | $400,000 | 2023 |
| NORTHWESTERN UNIVERSITY | Not stated | $400,000 | 2019 |
| NUAGO THERAPEUTICS INC | Not stated | $400,000 | 2024 |
| NUAGO THERAPEUTICS INC | Not stated | $400,000 | 2025 |
| O2M TECHNOLOGIES LLC | Not stated | $400,000 | 2023 |
| O2M TECHNOLOGIES LLC | Not stated | $400,000 | 2024 |
| ONCOTAB, INC. | Not stated | $400,000 | 2021 |
| ONCOTAB, INC. | Not stated | $400,000 | 2025 |
| ORALIVA, INC. | Not stated | $400,000 | 2025 |
| ORLANCE, INC | Not stated | $400,000 | 2023 |
| PARABON NANOLABS, INC. | Not stated | $400,000 | 2021 |
| PENSIEVISION, INC. | Not stated | $400,000 | 2021 |
| PRECISION MICROWAVE INC. | Not stated | $400,000 | 2022 |
| PROMILEAD, LLC | Not stated | $400,000 | 2025 |
| QUENCH MEDICAL INC. | Not stated | $400,000 | 2020 |
| RAVEN BIOMATERIALS LLC | Not stated | $400,000 | 2022 |
| RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | Not stated | $400,000 | 2024 |
| SENEX BIOTECHNOLOGY INC | Not stated | $400,000 | 2022 |
| SENEX BIOTECHNOLOGY INC | Not stated | $400,000 | 2025 |
| SOMAGENE INC | Not stated | $400,000 | 2020 |
| SOSTOS INC. | Not stated | $400,000 | 2024 |
| TENVOS INC. | Not stated | $400,000 | 2024 |
| THE REGENTS OF THE UNIVERSITY OF COLORADO | Not stated | $400,000 | 2024 |
| THE TINY CARGO COMPANY | Not stated | $400,000 | 2023 |
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | Not stated | $400,000 | 2023 |
| THOMAS JEFFERSON UNIVERSITY | Not stated | $400,000 | 2022 |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | Not stated | $400,000 | 2024 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | Not stated | $400,000 | 2022 |
| UP THERAPEUTICS LLC | Not stated | $400,000 | 2022 |
| VESICLE THERAPEUTICS INC | Not stated | $400,000 | 2025 |
| WEATHERWAX BIOTECHNOLOGIES CORP | Not stated | $400,000 | 2024 |
| WNTRIX, INC. | Not stated | $400,000 | 2023 |
| YALE UNIV | Not stated | $400,000 | 2022 |
| ZEEST BIO INC | Not stated | $400,000 | 2025 |
| ELECTRONIC BIOSCIENCES, INC. | Not stated | $399,999 | 2021 |
| ENZYME BY DESIGN INC | Not stated | $399,999 | 2020 |
| KEYWISE, INC | Not stated | $399,999 | 2025 |
| KUBANDA CRYOTHERAPY | Not stated | $399,999 | 2021 |
| SACYL PHARMACEUTICALS, INC. | Not stated | $399,999 | 2025 |
| SANARENTERO LLC | Not stated | $399,999 | 2023 |
| STEMSYNERGY THERAPEUTICS INC | Not stated | $399,999 | 2022 |
| THERANOSTEC INC | Not stated | $399,999 | 2022 |
| UNIVERSITY OF WASHINGTON | Not stated | $399,999 | 2023 |
| WILDFLOWER BIOPHARMA INC | Not stated | $399,999 | 2020 |
| DARWIN BIOSCIENCES, INC. | Not stated | $399,998 | 2025 |
| NEONC TECHNOLOGIES HOLDINGS INC. | Not stated | $399,998 | 2025 |
| OLEOLIVE, INC. | Not stated | $399,998 | 2022 |
| ARUNA BIO, INC. | Not stated | $399,997 | 2025 |
| MYOLEX, INC. | Not stated | $399,996 | 2025 |
| CAPSULOMICS INC | Not stated | $399,995 | 2021 |
| OMNECOIL INSTRUMENTS, INC. | Not stated | $399,995 | 2025 |
| PATHWARE INC. | Not stated | $399,994 | 2023 |
| CHARLES RIVER ANALYTICS, INC. | Not stated | $399,988 | 2025 |
| AXONEURAL THERAPEUTICS, INC. | Not stated | $399,987 | 2021 |
| CHILDREN'S RESEARCH INSTITUTE | Not stated | $399,987 | 2019 |
| THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER | Not stated | $399,985 | 2020 |
| VERAMORPH LLC | Not stated | $399,985 | 2025 |
| SEAK THERAPEUTICS, LLC | Not stated | $399,981 | 2025 |
| TRIPILL BIOTECHNOLOGY, CORP. | Not stated | $399,981 | 2024 |
| NAVIGATION SCIENCES INC | Not stated | $399,975 | 2021 |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Not stated | $399,974 | 2020 |
| MDDX INC | Not stated | $399,972 | 2021 |
| DUO ONCOLOGY INC. | Not stated | $399,970 | 2024 |
| DEEP CREEK PHARMA LLC | Not stated | $399,968 | 2025 |
| CLOVERLEAF BIO, INC. | Not stated | $399,966 | 2025 |
| SEAK THERAPEUTICS, LLC | Not stated | $399,964 | 2020 |
| MABSWITCH INC | Not stated | $399,958 | 2023 |
| TRAVERSE BIOTECH II INC | Not stated | $399,955 | 2023 |
| HIGHLAND INSTRUMENTS INC | Not stated | $399,954 | 2023 |
| METASTX, INC. | Not stated | $399,954 | 2025 |
| CYTOVERIS INC | Not stated | $399,948 | 2021 |
| SMART INFORMATION FLOW TECHNOLOGIES LLC | Not stated | $399,948 | 2023 |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | Not stated | $399,942 | 2018 |
| UNIVERSITY OF ILLINOIS | Not stated | $399,931 | 2023 |
| ATLASXOMICS INC | Not stated | $399,929 | 2024 |
| KINARX, INC | Not stated | $399,924 | 2020 |
| BRIACELL THERAPEUTICS CORP | Not stated | $399,918 | 2023 |
| POP BIOTECHNOLOGIES INC | Not stated | $399,917 | 2020 |
| ACCURE HEALTH INC | Not stated | $399,913 | 2022 |
| MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION) | Not stated | $399,911 | 2025 |
| TRUSTEES OF BOSTON UNIVERSITY | Not stated | $399,910 | 2019 |
| TRITERPENOID THERAPEUTICS INC | Not stated | $399,908 | 2020 |
| ATHNA BIOTECH INC | Not stated | $399,907 | 2022 |
| UNIVERSITY OF LOUISVILLE | Not stated | $399,902 | 2024 |
Source: USASpending.gov federal award records. Federal awards only. Last synced 2026-09-15.
What this funder funds
Derived from how this funder's 749 linked opportunities are classified, not from a funding strategy the funder published.
- Health & Human Services749
- Education135
- Environment & Water46
- Food & Nutrition34
Currently open opportunities
Verified against each record's own source. The date on every row is the day we last checked that record — not the day this page was built.
- Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Centers for Genomics Research Capacity BuildingCloses Not statedChecked 2026-11-10
- Limited Competition: Community-Partnered Nursing Research Centers for Schools and Colleges of Nursing with Limited NIH Funding (P20 Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Environmental Determinants of Diabetes in The Young Study (TEDDY) Data Coordinating Center (U01 Clinical Trial Not Allowed)Closes Not statedAwards up to $6,000,000Checked 2026-11-10
- Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research CentersCloses Not statedChecked 2026-11-10
- Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- NIEHS Worker Training Program’s SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Infrastructure for Population Dynamics Research Program (iPOP)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional)Closes Not statedChecked 2026-11-10
- Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional)Closes Not statedChecked 2026-11-10
- Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional)Closes Not statedChecked 2026-11-10
- Notice of Intent to Publish a Funding Opportunity Announcement for HIV Pediatric, Adolescent and Maternal Clinical TrialsCloses Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed)Closes Not statedChecked 2026-11-10
- Funding Opportunity Announcement for Impact of Environmental Exposures on Gut-Brain Signaling in Neurological Conditions (R01)Closes Not statedChecked 2026-11-10
- Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent DevelopmentCloses Not statedChecked 2026-11-10
- Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed)Closes Not statedChecked 2026-11-10
- Forecast to Publish a Notice of Funding Opportunity Announcement for Addressing Determinants of Health Disparities Among Rural Populations (R01 - Clinical Trial Optional)Closes Not statedChecked 2026-11-10
- Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required)Closes Not statedChecked 2026-11-10
What this funder’s awards look like
Counted over the award rows we hold for this funder. These are statistics over published records, not a model’s reading of them, and not a prediction.
Awards on file144626
Distinct recipients5767
Median award$1,389,137
Included with Studio
The counts and the median above stay free, because they are the evidence for everything else. Studio adds the breakdowns: which states the awards went to, what kind of organisation received them, and how the amounts are distributed.
See what Studio includes